The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classification
Hiroyuki Yamazaki(Hokkaido University), Hidemichi Watari(Hokkaido University of Science), Yosuke Konno(Hokkaido University of Science), Yoshihiro Matsuno(Hokkaido University Hospital), Yutaka Hatanaka(Hokkaido University), Ryosuke Matsuoka(International University of Health and Welfare), Hiroshi Asano(Hokkaido University), Kanako C. Hatanaka(Hokkaido University Hospital)
Cited by 12
Related Papers
Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter Study
|Journal of Thoracic Oncology|2016|273
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
|Cancer Research|2016|178
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
|Journal of Experimental & Clinical Cancer Research|2019|164
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
|Oncotarget|2014|155
The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
|Journal of Translational Medicine|2014|129